Humacyte, Inc., a clinical biotechnology foundation company developing bioengineered human tissues that can be transplanted commercially, has received in-principle approval of Humacyte's Biologics License Application (BLA)
In light of the growing threat of antimicrobial resistance (AMR), drug regulators have an important role in addressing the current global threat, largely due to the misuse and underuse of antibiotics. Dr Subhash C Mandal is the chairman of Regulatory
Vicore Pharma Holding AB, an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), has entered into an exclusive licensing agreement with Nippon S
Yatharth Hospital and Trauma Care Services announced the all-cash acquisition of Asian Fidelis Hospital, a multi-specialty hospital with 175 beds in Faridabad, for Rs 116 crore. Yatharth Clinic said it has gone into a conclusive concurrence with...
Theriva Biologics, a broadened clinical-stage organization creating therapeutics intended to treat malignant growth and related sicknesses in areas of high neglected need, declared that the Free Information Observing Panel (IDMC) suggested the...
pharmaceutical companies, high-quality biologics ,partnership
Bristol Myers Squibb has launched two clinical trials for neoadjuvant Opdivo (nivolumab) and adjuvant Opdivo and postoperative chemotherapy for the treatment of unresectable stages IIA to IIIB small resectable breast cancer (NSCLC).
BioNTech SE, a next-generation immunotherapy company developing new treatments for cancer and other malignancies, and Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing clinical T-medicine.
Chugai Pharmaceutical Co., Ltd. said. 'Crobalimab,' an anti-C5 monoclonal antibody discovered by Chugai, has been approved by China's National Medical Products Administration (NMPA) as a treatment for adults and adolescents (adolescents or 12 years).
Biocomposites, a global clinical gadgets organization that designers, makes and markets world driving items for use in contamination the executives in bone and delicate tissue, reports the send off of two stage II clinical preliminaries of...
, CDSCO.jpg)
